GlaxoSmithKline Pharmaceuticals 1st Quarter Net Profit Up 13%
April 27 2010 - 07:27AM
Dow Jones News
GlaxoSmithKline Pharmaceuticals Ltd. (500660.BY) Tuesday said
first-quarter net profit rose 13% to INR1.61 billion from INR1.43
billion a year earlier, beating analysts' estimates.
The Indian unit of GlaxoSmithKline PLC (GSK.LN) said net sales
in the three months ended March 31 rose 18% to INR5.41 billion from
INR4.57 billion.
A Dow Jones Newswires poll of seven analysts had expected a net
profit of INR1.42 billion on net sales of INR5.22 billion.
The company didn't immediately provide a reason for the rise in
earnings.
By Rumman Ahmed, Dow Jones Newswires; 91-9845104173;
rumman.ahmed@dowjones.com
Order free Annual Report for GlaxoSmithKline plc
Visit http://djnweurope.ar.wilink.com/?ticker=GB0009252882 or
call +44 (0)208 391 6028
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024